Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Celecoxib in Breast Cancer
NCT01695226Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Feb 2004
- Primary completion
- Jul 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Celecoxib with Placebo (2 arms). Primary endpoint: Whole-genome expression after celecoxib treatment. Started Feb 2004; status: completed.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01695226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01695226.